FI117616B - Farmaseuttinen seos, joka sisältää ACE-inhibiittorin ramipriilin ja dihydropyridiiniyhdisteen - Google Patents

Farmaseuttinen seos, joka sisältää ACE-inhibiittorin ramipriilin ja dihydropyridiiniyhdisteen Download PDF

Info

Publication number
FI117616B
FI117616B FI961863A FI961863A FI117616B FI 117616 B FI117616 B FI 117616B FI 961863 A FI961863 A FI 961863A FI 961863 A FI961863 A FI 961863A FI 117616 B FI117616 B FI 117616B
Authority
FI
Finland
Prior art keywords
ramipril
pharmaceutical preparation
preparation according
dihydropyridine
pharmaceutically acceptable
Prior art date
Application number
FI961863A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI961863A (fi
FI961863A0 (fi
Inventor
Brigitte Bauer
Christer Karlsson
Per Johan Lundberg
Berit Nilsson
Anders Sandberg
Alfred Sickmueller
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9402925A external-priority patent/SE9402925D0/xx
Priority claimed from SE9402924A external-priority patent/SE9402924D0/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI961863A publication Critical patent/FI961863A/fi
Publication of FI961863A0 publication Critical patent/FI961863A0/fi
Application granted granted Critical
Publication of FI117616B publication Critical patent/FI117616B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
FI961863A 1994-09-02 1996-05-02 Farmaseuttinen seos, joka sisältää ACE-inhibiittorin ramipriilin ja dihydropyridiiniyhdisteen FI117616B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SE9402925A SE9402925D0 (sv) 1994-09-02 1994-09-02 Novel oral pharmaceutical composition
SE9402924 1994-09-02
SE9402925 1994-09-02
SE9402924A SE9402924D0 (sv) 1994-09-02 1994-09-02 Novel pharmaceutical composition
PCT/SE1995/000972 WO1996007400A1 (en) 1994-09-02 1995-08-30 Novel pharmaceutical composition containing the ace inhibitor ramipril and a dihydropyridine compound
SE9500972 1995-08-30

Publications (3)

Publication Number Publication Date
FI961863A FI961863A (fi) 1996-05-02
FI961863A0 FI961863A0 (fi) 1996-05-02
FI117616B true FI117616B (fi) 2006-12-29

Family

ID=26662130

Family Applications (1)

Application Number Title Priority Date Filing Date
FI961863A FI117616B (fi) 1994-09-02 1996-05-02 Farmaseuttinen seos, joka sisältää ACE-inhibiittorin ramipriilin ja dihydropyridiiniyhdisteen

Country Status (33)

Country Link
US (1) US6086919A (zh)
EP (1) EP0726766B1 (zh)
JP (1) JP3776931B2 (zh)
KR (1) KR100438133B1 (zh)
CN (1) CN1134665A (zh)
AT (1) ATE217187T1 (zh)
AU (1) AU695865B2 (zh)
CA (1) CA2174338C (zh)
CZ (1) CZ292224B6 (zh)
DE (2) DE726766T1 (zh)
DK (1) DK0726766T3 (zh)
EE (1) EE03550B1 (zh)
EG (1) EG24435A (zh)
ES (1) ES2091173T3 (zh)
FI (1) FI117616B (zh)
GR (1) GR960300055T1 (zh)
HK (1) HK1001811A1 (zh)
HU (1) HU226894B1 (zh)
IL (1) IL115059A (zh)
IS (1) IS1781B (zh)
MX (1) MX9601586A (zh)
MY (1) MY119489A (zh)
NO (1) NO308694B1 (zh)
NZ (2) NZ292298A (zh)
PL (1) PL186745B1 (zh)
PT (1) PT726766E (zh)
RU (1) RU2184563C2 (zh)
SA (1) SA95160287B1 (zh)
SI (1) SI0726766T1 (zh)
SK (1) SK283633B6 (zh)
TR (1) TR199501077A2 (zh)
TW (1) TW483763B (zh)
WO (1) WO1996007400A1 (zh)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19715594A1 (de) 1997-04-15 1998-10-22 Bayer Ag Analgetika-Kombination
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
PE20001302A1 (es) * 1998-11-27 2000-11-30 Hoffmann La Roche Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida
KR100356374B1 (ko) * 2000-09-14 2002-10-19 사회복지법인삼성생명공익재단(삼성서울병원) 안지오텐신 전환효소 억제제의 부작용으로 발생하는마른기침을 저해하기 위한 철분을 포함하는 기침 저해조성물
CA2357982A1 (en) * 2001-09-28 2003-03-28 Bernard Charles Sherman Solid compositions comprising ramipril
BR0306928A (pt) * 2002-01-15 2004-11-09 Ranbaxy Lab Ltd Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
US6844361B2 (en) * 2002-02-04 2005-01-18 Aventis Pharma Deutschland Gmbh Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor
US20030175342A1 (en) * 2002-03-14 2003-09-18 Karl Kolter Coated pharmaceutical single-unit delayed-release forms, based on polyvinyl acetate
US20030211149A1 (en) * 2002-05-07 2003-11-13 Sherman Bernard Charles Extended release tablets comprising felodipine
US6663892B1 (en) 2002-08-19 2003-12-16 L. Perrigo Company Multiple portion tablet
US20040147566A1 (en) * 2002-10-16 2004-07-29 Amedeo Leonardi Lisinopril/lercanidipine combination therapy
US20050101640A1 (en) * 2002-10-16 2005-05-12 Recordati Ireland Limited Lisinopril/lercanidipine combination therapy
CN100348189C (zh) * 2002-12-10 2007-11-14 诺瓦提斯公司 DPP－IV抑制剂与PPAR－α化合物的组合
GB0301471D0 (en) * 2003-01-22 2003-02-19 Biochemie Gmbh Organic compounds
ES2322854T3 (es) * 2003-06-26 2009-06-30 Teva Pharmaceutical Industries Limited Composiciones farmaceuticas estables de derivados del acido 2-aza-biciclo(3.3.0)-octano-3-carboxilico.
BRPI0414719A (pt) * 2003-09-24 2006-11-21 Combinatorx Inc regimes terapêuticos para administrar combinações de fármacos
DE102004008804A1 (de) * 2004-02-20 2005-09-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mehrschichttablette
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
TW200534879A (en) * 2004-03-25 2005-11-01 Bristol Myers Squibb Co Coated tablet formulation and method
US7829720B2 (en) * 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
US20050256314A1 (en) * 2004-05-04 2005-11-17 Soojin Kim Process employing controlled crystallization in forming crystals of a pharmaceutical
US20050288343A1 (en) * 2004-05-19 2005-12-29 Andrew Rusowicz Process of preparing substituted carbamates and intermediates thereof
US7622137B2 (en) * 2004-05-21 2009-11-24 Accu-Break Technologies, Inc. Dosage forms contained within a capsule or sachet
US7318935B2 (en) * 2004-05-21 2008-01-15 Accu-Break Technologies, Inc. Pharmaceutical tablets with active and inactive segments
US7780985B2 (en) * 2005-07-12 2010-08-24 Accu-Break Technologies, Inc. Tablets having a printed separation mark to guide breaking
US7329418B2 (en) * 2004-05-21 2008-02-12 Accu Break Technologies, Inc. Pharmaceutical tablets having height greater than width
AU2005245028B2 (en) * 2004-05-21 2010-12-09 Accu-Break Technologies, Inc. Pharmaceutical tablets having a relatively inactive segment
US7838031B2 (en) 2004-05-21 2010-11-23 Lawrence Solomon Method of administering a partial dose using a segmented pharmaceutical tablet
US7713547B2 (en) 2004-05-21 2010-05-11 Accu-Break Pharmaceuticals, Inc. Method of administering a partial dose of a segmented pharmaceutical tablet
TWI354569B (en) * 2004-05-28 2011-12-21 Bristol Myers Squibb Co Coated tablet formulation and method
KR100593795B1 (ko) 2004-10-12 2006-06-30 대원제약주식회사 안정성이 개선된 라미프릴을 포함하는 경구투여용 제제
MX2007005373A (es) * 2004-11-05 2007-08-14 King Pharmaceuticals Res & Dev Composiciones estabilizadas de ramipril y metodos para elaborarlas.
KR100714616B1 (ko) * 2005-06-23 2007-05-07 삼성전기주식회사 지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
US20070196465A1 (en) * 2005-07-28 2007-08-23 George Bobotas Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof
CA2628955A1 (en) * 2005-11-07 2007-05-18 Edward S. Wilson Compositions of stabilized ramipril in combination with another active agent
JP5259413B2 (ja) * 2005-11-18 2013-08-07 エーシーシーユー−ブレイク テクノロジーズ，インク． セグメント化した薬の剤形
US20070237815A1 (en) * 2006-04-06 2007-10-11 Lawrence Solomon Dosage forms and methods comprising amlodipine and chlorthalidone
US20080015188A1 (en) * 2006-04-19 2008-01-17 Julia Hrakovsky Stable pharmaceutical compositions of 2-aza-bicyclo(3.3.0)-octane-3-carboxylic acid derivatives
EP2049087A2 (en) * 2006-07-21 2009-04-22 LAB International SRL Hydrophilic abuse deterrent delivery system
JP2010500374A (ja) * 2006-08-08 2010-01-07 エーシーシーユー−ブレイク テクノロジーズ，インク． 複数の活性セグメントを含む薬剤の錠剤
US20100068271A1 (en) * 2006-11-30 2010-03-18 Accu-Break Technologies, Inc Divisible Osmotic Dosage Forms and Methods of Use
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
EP2178511B1 (en) * 2007-06-22 2011-03-02 Bristol-Myers Squibb Company Tableted compositions containing atazanavir
JP2010530890A (ja) * 2007-06-22 2010-09-16 ブリストル−マイヤーズ スクイブ カンパニー アタザナビルを含む錠剤組成物
ES2449074T3 (es) * 2007-06-22 2014-03-18 Bristol-Myers Squibb Holdings Ireland Composiciones en forma de comprimidos que contienen atazanavir
AU2008268537B2 (en) * 2007-06-22 2012-11-01 Bristol-Myers Squibb Holdings Ireland Tableted compositions containing atazanavir
US20110027356A1 (en) * 2008-01-25 2011-02-03 Duo-Ge Combination of Oral Medicaments Bonded by a Wrapping
JP5295356B2 (ja) 2008-07-28 2013-09-18 武田薬品工業株式会社 医薬組成物
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
CN101843892B (zh) * 2010-05-18 2013-03-06 广州白云山制药股份有限公司广州白云山制药总厂 包括依那普利速释部分和非洛地平缓释部分的药物组合物制剂

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
DE2117571C3 (de) * 1971-04-10 1979-10-11 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin-33-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
DE3413710A1 (de) * 1984-04-12 1985-10-24 Hoechst Ag, 6230 Frankfurt Verfahren zur behandlung der herzinsuffizienz
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
CA1323833C (en) * 1987-04-28 1993-11-02 Yatindra M. Joshi Pharmaceutical compositions in the form of beadlets and method
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
TW197945B (zh) * 1990-11-27 1993-01-11 Hoechst Ag
DE4109134A1 (de) * 1991-03-20 1992-09-24 Knoll Ag Erzeugnisse, enthaltend verapamil und trandolapril
CA2070085A1 (en) * 1991-05-31 1992-12-01 Gerald P. Polli Ace inhibitor and calcium channel blocker for use in treating hypertension
US5160744A (en) * 1991-06-27 1992-11-03 Alza Corporation Verapmil therapy
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
MX9706957A (es) * 1995-03-16 1997-11-29 Pfizer Composicion que contiene amlodipina, o una sal, o felodipina y un inhibidor de enzima convertidora de angiotensina.

Also Published As

Publication number Publication date
MX9601586A (es) 1998-01-31
CZ117396A3 (en) 1996-09-11
DK0726766T3 (da) 2002-07-22
PL314084A1 (en) 1996-08-19
CA2174338C (en) 2009-11-03
KR100438133B1 (ko) 2004-09-04
US6086919A (en) 2000-07-11
NO308694B1 (no) 2000-10-16
AU3402995A (en) 1996-03-27
FI961863A (fi) 1996-05-02
CA2174338A1 (en) 1996-03-14
IS1781B (is) 2001-10-01
CN1134665A (zh) 1996-10-30
IL115059A0 (en) 1996-01-19
ATE217187T1 (de) 2002-05-15
PT726766E (pt) 2002-10-31
HU9601146D0 (en) 1996-07-29
RU2184563C2 (ru) 2002-07-10
ES2091173T3 (es) 2002-12-01
TW483763B (en) 2002-04-21
SI0726766T1 (en) 2002-10-31
TR199501077A2 (tr) 1996-06-21
FI961863A0 (fi) 1996-05-02
IL115059A (en) 2003-10-31
NO961726D0 (no) 1996-04-29
DE726766T1 (de) 1997-01-30
PL186745B1 (pl) 2004-02-27
EP0726766A1 (en) 1996-08-21
HK1001811A1 (en) 1998-07-10
HU226894B1 (en) 2010-01-28
MY119489A (en) 2005-06-30
JP3776931B2 (ja) 2006-05-24
IS4337A (is) 1996-04-18
NZ292298A (en) 1998-02-26
CZ292224B6 (cs) 2003-08-13
DE69526640D1 (de) 2002-06-13
JPH09504806A (ja) 1997-05-13
WO1996007400A1 (en) 1996-03-14
SK55896A3 (en) 1997-03-05
NZ329556A (en) 2000-07-28
EP0726766B1 (en) 2002-05-08
DE69526640T2 (de) 2002-11-07
AU695865B2 (en) 1998-08-27
SA95160287A (ar) 2005-12-03
SA95160287B1 (ar) 2006-05-28
NO961726L (no) 1996-04-29
EE03550B1 (et) 2001-12-17
HUT76049A (en) 1997-06-30
ES2091173T1 (es) 1996-11-01
EG24435A (en) 2009-06-25
SK283633B6 (sk) 2003-11-04
EE9600072A (et) 1996-12-16
GR960300055T1 (en) 1996-10-31

Similar Documents

Publication Publication Date Title
FI117616B (fi) Farmaseuttinen seos, joka sisältää ACE-inhibiittorin ramipriilin ja dihydropyridiiniyhdisteen
US20160030399A1 (en) Method of reducing somnolence in patients treated with tizanidine
KR100845660B1 (ko) 서방성 파라세타몰 조성물
JP2010043111A (ja) アムロジピンとベナゼプリル／ベナゼプリラートの治療上の組み合せ
PL206069B1 (pl) Tabletka dwuwarstwowa zawierająca cetyryzynę i pseudoefedrynę
EP1223914B1 (en) Orally distintegrating composition comprising mirtazapine
RU2182002C2 (ru) Композиция с фиксированной дозой ингибитора ангиотензин-превращающего фермента и антагониста кальциевых каналов, способ ее изготовления и применение для лечения сердечно-сосудистых заболеваний
US7767227B2 (en) Galenical form for oral administration with prolonged release of molsidomine
Frishman A new extended‐release formulation of diltiazem HCl for the treatment of mild‐to‐moderate hypertension
CN101239036A (zh) 含有血管紧张素转化酶抑制剂雷米普利和二氢吡啶类化合物的新药物组合物
EP2848260B1 (en) Novel formulations of thiocolchicoside
UA43854C2 (uk) Фармацевтичний препарат для перорального прийому, спосіб одержання вказаного препарату (варіанти) та спосіб профілактики або лікування гіпертензії

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 117616

Country of ref document: FI

MA Patent expired